DIC075V
Phase 1Completed 0 watching 0 views this week💤 Quiet
32
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Ventricular Repolarization
Conditions
Ventricular Repolarization
Trial Timeline
May 1, 2009 → Jul 1, 2009
NCT ID
NCT01812538About DIC075V
DIC075V is a phase 1 stage product being developed by Pfizer for Ventricular Repolarization. The current trial status is completed. This product is registered under clinical trial identifier NCT01812538. Target conditions include Ventricular Repolarization.
Hype Score Breakdown
Clinical
10
Activity
5
Company
9
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01812538 | Phase 1 | Completed |
Competing Products
20 competing products in Ventricular Repolarization